TrialEuropean journal of cancer (Oxford, England : 1990)2021

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy.

Laura A Sena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.